概要
The DIA India Annual Meeting (IAM) 2026 marks a defining moment for India’s life sciences and healthcare ecosystem. As science, technology, and regulation converge at unprecedented speed, IAM 2026 emerges as the platform where future-ready strategies are shaped, tested, and translated into real-world impact.
Bringing together global and Indian leaders from pharma, biotech, medical devices, regulators, academia, and technology, IAM 2026 goes beyond dialogue-it enables decision-making, collaboration, and action across the full product lifecycle.
With six deep-dive tracks and two high-impact plenary sessions, this year’s meeting reflects the expanding scope and complexity of modern healthcare, from advanced therapies and digital innovation to regulatory transformation, patient safety, and evidence generation. IAM 2026 is designed for leaders who are not just adapting to change, but shaping what comes next.
Plenary Sessions (Flagship Conversations)
1. Plenary I: The Future of Healthcare Innovation
A global perspective on science, regulation, and patient-centric transformation
Senior leaders and regulators share their vision on how innovation, policy, and trust will define healthcare delivery in the next decade.
2. Plenary II: From Promise to Practice
Translating science into scalable, sustainable healthcare solutions
A cross-sector dialogue on execution-what it takes to move breakthrough ideas from labs to lives, at speed and with integrity.
Conference Tracks – 2026
1. Advanced Therapy Medicinal Products (ATMPs)
Cell & gene therapies, RNA-based medicines, personalized treatments, and platform technologies, exploring development, regulation, manufacturing, and access pathways for next-generation therapies.
2. Clinical Development
Advancing clinical and medical science and high-quality trial execution to deliver patient-centric evidence across the clinical development continuum, with India’s growing role in global clinical development.
3. Pharmacovigilance & Patient Safety
Next-generation safety systems, AI-enabled signal detection, risk management across products, and evolving global PV expectations.
4. Regulatory Science & Policy
Regulatory convergence, reliance pathways, digital submissions, evolving Indian and global frameworks, and science-driven decision-making.
5. Medical Affairs & Evidence Generation
Strategic medical leadership, real-world evidence, scientific engagement, and the expanding role of Medical Affairs in value creation.
6. Data Science, RWE & Artificial Intelligence
AI, advanced analytics, real-world data, interoperability, and governance—turning data into insight, trust, and better outcomes.
Why IAM 2026 Matters
IAM 2026 is not just a conference; it is a strategic convergence point for those committed to advancing healthcare in India and globally.
If you are looking to anticipate change, influence policy, adopt innovation responsibly, and deliver better outcomes for patients, this is where the conversation and the future begin.
プログラム委員会
-
Gaurav Mathur, PHD Senior Director, Regulatory Affairs
Parexel International, Bengaluru, India -
Sanish Davis R&D Director, GCO India
Johnson & Johnson Innovative Medicine, India -
Subrat Ray Regional Director Medical Affairs – Women’s Health (APJ and EEMEA)
Organon (India) Pvt Ltd, India -
Chitra Lele, PHD Managing Director, Life Sciences Consulting
NTT DATA, India -
Vivek Ahuja, MD Program Chair, Executive Vice President, Pharmacovigilance
EVERSANA, India -
Praveen Raj Medical Affairs Leader & Health Economics Expert
Biocon, India -
Sridevi Nagarajan, PHD DIA Communities Chair for AI in Healthcare
Ayusarogya, United Kingdom -
Ashok Kumar Swain, MD General Manager & Executive Director
DIA, India